465 related articles for article (PubMed ID: 26233944)
21. Antithrombotic therapy following bioprosthetic aortic valve replacement.
Nowell J; Wilton E; Markus H; Jahangiri M
Eur J Cardiothorac Surg; 2007 Apr; 31(4):578-85. PubMed ID: 17267235
[TBL] [Abstract][Full Text] [Related]
22. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
[TBL] [Abstract][Full Text] [Related]
23. Early postoperative thrombosis of an aortic bioprosthetic valve: should anticoagulation be patient specific?
Efthymiou CA; Mills RJ; O'Regan DJ
J Card Surg; 2013 Nov; 28(6):723-9. PubMed ID: 23992398
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China.
Zhang H; Dong Y; Ao X; Fu B; Dong L;
Cardiovasc Drugs Ther; 2021 Feb; 35(1):1-10. PubMed ID: 32940891
[TBL] [Abstract][Full Text] [Related]
25. Should we anticoagulate after bioprosthetic aortic valve replacement?
Al-Atassi T; Toeg H; Ruel M
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1649-57. PubMed ID: 24215195
[TBL] [Abstract][Full Text] [Related]
26. Optimal thromboprophylaxis following bioprosthetic aortic valve replacement: still a matter of debate?
Mydin MI; Dimitrakakis G; Younis J; Nowell J; Athanasiou T; Kourliouros A
Interact Cardiovasc Thorac Surg; 2012 Jul; 15(1):109-14. PubMed ID: 22493097
[TBL] [Abstract][Full Text] [Related]
27. Mitral valve repair and bioprosthetic replacement without postoperative anticoagulation does not increase the risk of stroke or mortality.
Schwann TA; Engoren M; Bonnell M; Clancy C; Khouri S; Kabour A; Jamil T; Habib RH
Eur J Cardiothorac Surg; 2013 Jul; 44(1):24-31. PubMed ID: 23293318
[TBL] [Abstract][Full Text] [Related]
28. [Inhibition of thrombocyte aggregation after heart valve replacement].
von Schacky C
Z Kardiol; 1998; 87 Suppl 4():46-55. PubMed ID: 9857467
[TBL] [Abstract][Full Text] [Related]
29. Are thromboembolic and bleeding complications a drawback for composite aortic root replacement?
Zafar MA; Farkas EA; Javier A; Anderson M; Gilani O; Elefteriades JA
Ann Thorac Surg; 2012 Sep; 94(3):737-43. PubMed ID: 22626762
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic management after aortic valve replacement with biological prosthesis: a meta-analysis.
Uimonen M; Kuitunen I; Ponkilainen V; Mennander A; Mattila MS
J Cardiothorac Surg; 2024 Jun; 19(1):385. PubMed ID: 38926789
[TBL] [Abstract][Full Text] [Related]
31. Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
Al-Atassi T; Lam K; Forgie M; Boodhwani M; Rubens F; Hendry P; Masters R; Goldstein W; Bedard P; Mesana T; Ruel M
Circulation; 2012 Sep; 126(11 Suppl 1):S239-44. PubMed ID: 22965989
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
[TBL] [Abstract][Full Text] [Related]
33. Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?
Jamieson WR; Moffatt-Bruce SD; Skarsgard P; Hadi MA; Ye J; Fradet GJ; Abel JG; Janusz MT; Cheung A; Germann E
Ann Thorac Surg; 2007 Feb; 83(2):549-56; discussion 556-7. PubMed ID: 17257986
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Colli A; Verhoye JP; Leguerrier A; Gherli T
Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
[TBL] [Abstract][Full Text] [Related]
35. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Gherli T; Colli A; Fragnito C; Nicolini F; Borrello B; Saccani S; D'Amico R; Beghi C
Circulation; 2004 Aug; 110(5):496-500. PubMed ID: 15289387
[TBL] [Abstract][Full Text] [Related]
36. [The difficult choice of antithrombotic therapy after bioprosthetic aortic valve implantation: aspirin, warfarin, or both?].
Marullo AG; Iacò AL; Calafiore AM
G Ital Cardiol (Rome); 2013 Apr; 14(4):246-7. PubMed ID: 23567764
[No Abstract] [Full Text] [Related]
37. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
[TBL] [Abstract][Full Text] [Related]
38. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Colli A; Mestres CA; Castella M; Gherli T
J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
[TBL] [Abstract][Full Text] [Related]
39. Antithrombotic therapy after mitral valve repair: VKA or aspirin?
van der Wall SJ; Olsthoorn JR; Heuts S; Klautz RJM; Tomsic A; Jansen EK; Vonk ABA; Sardari Nia P; Klok FA; Huisman MV
J Thromb Thrombolysis; 2018 Nov; 46(4):473-481. PubMed ID: 30132244
[TBL] [Abstract][Full Text] [Related]
40. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
